Results 101 to 110 of about 594 (120)

Daily Herald, June, 04, 1980 [PDF]

, 1980

core  

Contributions regarding the bioecological and control measures parameters of horsechestnut leaf miner moth Cameraria ndash; ohridella Deskha, Dimič under climate area condition of Cluj-Napoca, Romania

, 2009
Perju, T., Trifan, G.
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Guignardia leaf blotch of horsechestnut

Transactions of the British Mycological Society, 1987
Single ascospore isolates of Guignardia aesculi from leaves of Aesculus hippocastanum produced the anamorph Phyllosticta sphaeropsoidea. Both conidia and ascospores produced characteristic lesions on leaves of A. hippocastanum 4–6 weeks after inoculation.
openaire   +1 more source

Phylogenomics, co-evolution of ecological niche and morphology, and historical biogeography of buckeyes, horsechestnuts, and their relatives (Hippocastaneae, Sapindaceae) and the value of RAD-Seq for deep evolutionary inferences back to the Late Cretaceous

Molecular Phylogenetics and Evolution, 2020
In this study, we used RAD-seq data to resolve the phylogeny of the tribe Hippocastaneae (Sapindaceae) and conducted comparative analyses to gain insights into the evolution and biogeography of the group that had fossils dating back to the late Cretaceous.
Zhi-Yuan, Du, A J, Harris, Qiu-Yun Jenny, Xiang   +2 more
openaire   +2 more sources

Barriers to conducting randomised controlled trials: Lessons learnt from the Horsechestnut & Venous Leg Ulcer Trial (HAVLUT)

Contemporary Nurse, 2003
The RCT is considered the gold standard for testing a therapeutic intervention. However, the conduct of an RCT is not without numerous obstacles. As illustrated through the recent Horsechestnut and Venous Leg Ulcer Trial (HAVLUT), these barriers can be attributed to randomisation, recruitment, retention, blinding and sampling procedures, and to gate ...
openaire   +2 more sources

The clinical feasibility of natural medicine, venotonic therapy and horsechestnut seed extract in the treatment of venous leg ulceration: a descriptive survey

Complementary Therapies in Nursing and Midwifery, 2004
The primary treatment of choice for venous leg ulceration (VLU) is compression therapy; however, serious clinical issues demand the development of new treatments. An extract believed to promote VLU healing is Horsechestnut Seed Extract (HCSE).The clinical feasibility of HCSE in VLU was explored in a two-stage design.
openaire   +3 more sources

Using horsechestnut seed extract in the treatment of venous leg ulcers: a cost-benefit analysis.

Ostomy/wound management, 2006
Venous leg ulcers affect approximately 0.6% of the western population, consuming millions of healthcare dollars every year. To determine whether an alternative venous ulcer treatment using horsechestnut seed extract-- Aesculus hippocastanum-- and conventional therapy involving dressings and compression was more cost-effective than using conventional ...
Matthew J, Leach, Jan, Pincombe, Gigi, Foster   +2 more
openaire   +1 more source

Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies.

International angiology : a journal of the International Union of Angiology, 2003
Safe and effective oral therapies for chronic venous insufficiency (CVI) would provide an important alternative to mechanical compression treatment. Several narrative reviews and one systematic review have summarized the efficacy of horse chestnut seed extract (HCSE), but to our knowledge no systematic review has included data from both randomized ...
U, Siebert, M, Brach, G, Sroczynski, K, Berla   +3 more
openaire   +1 more source